BioLive Wire · AI-collected
Supply Chain Woes Send Stryker Stock Tumbling 7.7%
- Supply chain woes sent Stryker stock tumbling 7.7%, according to an Investing.com report.
Published Sep 8Source: Investing.com ↗
NLP · 3-line summary
AI Articles & Report Summaries
Expert articles and reports as a 3-line summary + takeaway
BioLive Wire · AI-collected
Novartis's Failed Trial for Cholesterol Drug Leads to Broad Biopharma Stock Selloff
- Novartis's failed trial for a cholesterol drug led to a broad biopharma stock selloff, according to a MarketWatch report.
- Along with several other drugmakers, Novartis had bet that lowering Lp(a) would cut the risk of sometimes-fatal cardiovascular events, the report said.
Published Sep 8Source: MarketWatch ↗
BioLive Wire · AI-collected
Boston Scientific Says Cyberattack Likely to Hurt 2026 Sales, Profit
- Boston Scientific said a cyberattack is likely to hurt its 2026 sales and profit, according to an Investing.com report.
Published Sep 8Source: Investing.com ↗
BioLive Wire · AI-collected
Sandoz Gains 5% as Biosimilars Fuel Ambitious 2035 Growth Target
- Sandoz shares gained 5% as biosimilars fuel an ambitious 2035 growth target, according to an Investing.com report.
Published Sep 8Source: Investing.com ↗
BioLive Wire · AI-collected
Novo Nordisk Says Semaglutide Cut Obesity Rates in Young Children in Trial
- Novo Nordisk said semaglutide cut obesity rates in young children in a trial, according to an Investing.com report.
Published Sep 7Source: Investing.com ↗
BioLive Wire · AI-collected
Novartis Shares Fall After Heart Drug Fails Late-Stage Trial
- Novartis shares fell after its heart drug failed a late-stage trial, according to an Investing.com report.
Published Sep 7Source: Investing.com ↗
BioLive Wire · AI-collected
Spire Healthcare Shares Jump 3% on £1.03 Billion Takeover Deal
- Spire Healthcare shares jumped 3% on a £1.03 billion takeover deal, according to an Investing.com report.
Published Sep 7Source: Investing.com ↗
BioLive Wire · AI-collected
Sectra Q1 Sales Rise 25.8% as Cloud Revenue Crosses SEK 1 Billion
- Swedish medical imaging IT company Sectra reported Q1 sales rose 25.8%, according to an Investing.com report.
- Cloud revenue crossed SEK 1 billion for the first time, the report said.
Published Sep 4Source: Investing.com ↗
BioLive Wire · AI-collected
KKR Sells Nordic Bioscience Stake Back to Founder
- KKR sold its stake in Nordic Bioscience back to the company's founder, according to an Investing.com report.
- The report did not specify the transaction value.
Published Sep 3Source: Investing.com ↗
BioLive Wire · AI-collected
Olympus-Backed Accelevation Files for US IPO
- Olympus-backed Accelevation filed for a US IPO, according to Reuters via Investing.com.
Published Sep 2Source: Investing.com ↗
BioLive Wire · AI-collected
Definitive Healthcare Stock Surges 13% on Advent Buyout Offer
- Definitive Healthcare shares surged 13% on an Advent buyout offer, according to Investing.com.
Published Sep 2Source: Investing.com ↗
BioLive Wire · AI-collected
Medtronic Raises FY27 Outlook After Reporting Strong Q1 Growth
- Medtronic raised its FY27 outlook after reporting strong Q1 growth, according to Medical Device Network via Yahoo Finance.
Published Sep 2Source: Yahoo Finance ↗
BioLive Wire · AI-collected
Electra Therapeutics Files for IPO to Fund Immune Disease Drugs
- Electra Therapeutics filed for an IPO to fund immune disease drugs, according to Investing.com.
Published Aug 28Source: Investing.com ↗
BioLive Wire · AI-collected
BioNTech Drops 10% on mRNA Trial Failure, Highlighting Moderna Contrast
- BioNTech shares dropped 10% on an mRNA trial failure, highlighting a contrast with Moderna, according to Investing.com.
Published Aug 28Source: Investing.com ↗
BioLive Wire · AI-collected
US FDA Approves Updated COVID Vaccines for 2026-27 Season
- The U.S. FDA has approved updated COVID vaccines for the 2026-27 season, according to Investing.com.
Published Aug 27Source: Investing.com ↗
BioLive Wire · AI-collected
Ozempic Maker Novo Nordisk Downgraded to Sell After 70% Stock-Price Dive From Peak
- Novo Nordisk was downgraded to sell after a 70% stock-price dive from its peak, according to MarketWatch.
- Deutsche Bank issued the downgrade on Thursday.
Published Aug 27Source: MarketWatch ↗
BioLive Wire · AI-collected
Moderna's Cancer Vaccine Milestone Contrasts With Deep Financial Losses
- Moderna's cancer vaccine milestone stands in contrast with the company's deep financial losses, according to Investing.com.
Published Aug 20Source: Investing.com ↗
BioLive Wire · AI-collected
Novonesis Leads Europe's Stoxx 600 on Sales Beat, Guidance Raise
- Novonesis, which develops enzymes, probiotics and other biological products, led gains on Europe's Stoxx 600 after posting organic sales growth ahead of consensus estimates and raising guidance, according to the Wall Street Journal.
Published Aug 20Source: WSJ ↗
BioLive Wire · AI-collected
BofA Upgrades Moderna After 177% Rally Driven by Cancer Vaccine Breakthrough
- Bank of America upgraded Moderna after its shares rallied 177%, driven by the company's cancer vaccine breakthrough, according to Investing.com.
Published Aug 20Source: Investing.com ↗
BioLive Wire · AI-collected
Ultragenyx Stock Surges on FDA Gene Therapy Approval
- Ultragenyx shares surged after the company received FDA approval for a gene therapy, according to Investing.com.
Published Aug 19Source: Investing.com ↗
BioLive Wire · AI-collected
Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally
- Moderna's cancer-vaccine breakthrough drove a broad rally across biopharma stocks, according to MarketWatch.
- The biopharmaceutical sector had struggled with a prolonged downturn in recent years but has been on an upswing of late.
Published Aug 19Source: MarketWatch ↗
BioLive Wire · AI-collected
Moderna Shares Soar on Melanoma Drug Trial Success
- Moderna shares soared following the success of a melanoma drug trial, according to an Investing.com report.
Published Aug 19Source: Investing.com ↗
BioLive Wire · AI-collected
Trump Selects Heidi Overton to Lead FDA, Bloomberg Reports
- President Trump selected Heidi Overton to lead the FDA, according to a Bloomberg report cited by Investing.com.
Published Aug 19Source: Investing.com ↗
BioLive Wire · AI-collected
BioMarin Stock Surges on $275 Million Alesta Acquisition Deal
- BioMarin Pharmaceutical shares surged after the company announced a $275 million acquisition deal for Alesta, according to an Investing.com report.
Published Aug 18Source: Investing.com ↗